Document is current
Any future updates will be listed below
-
Authors
Akita, Keitaro
Kusunose, Kenya
Haga, Akihiro
Shimomura, Taisei
Kosaka, Yoshitaka
Ishiyama, Katsunori
Hasegawa, Kohei
Fifer, Michael A.
Maurer, Mathew S.
Shimada, Yuichi J.
-
Funding
Funding for this research was provided by:
National Institutes of Health (K24 AG036778, R01 HL157216)
Akcea
Alnylam Pharmaceuticals
Eidos Therapeutics
Pfizer
Prothena
Novo Nordisk
Intellia
American Heart Association (National Clinical and Population Research Award)
Korea Institute of Oriental Medicine (W22005)
Feldstein Medical Foundation
Irving Medical Center, Columbia University (Precision Medicine Pilot Award)
- License Information
-
More Information
Article History
Received: 7 March 2024
Accepted: 6 August 2024
First Online: 14 October 2024
Declarations
:
: The review board of Columbia University Irving Medical Center and Tokushima University Hospital approved the study protocol and all participants provided written informed consent to participate in the study before taking part.
: This study does not have a clinical trial number as this is not a clinical trial.
: Not applicable.
: The authors declare no competing interests.
